Consumers paid lower average prices for cannabis goods in September, according to recently released BDS Analytics Cannabis Retail Price Index data.
The CPI, a benchmark of retail sales of cannabis products across legalized markets calculated by Boulder-based BDS Analytics Inc., was 102.29 in September, the most recent month with available data. That’s a decrease of 4 percentage points compared with the previous month and a drop of 2 percentage points versus September 2018. The index uses January 2018 prices as a baseline at 100.
How often have you started to write a memo on policy updates, an annual report or even an email only to find yourself staring at a blank screen? Many professionals struggle to get started writing — even though they have a general idea of what they should say, they don’t know what to say first.
Legal cannabis sales at dispensaries across Arizona, California, Colorado, Oregon and Washington totaled $582.9 million in September, down 9 percent from August but up 15 percent from September 2018.
“Historically, September is a period of seasonal slowdowns,” according to BDS’ report. “In fact, from August to September in 2018, dollar sales decreased by more than four percent. This year’s seasonal decline of nine percent was exacerbated by health and safety concerns related to vaping. As a result of these vape-related concerns, sales in the category declined by 21 percent from the trailing month. As vape sales ceded ground to lower-priced categories, overall prices declined while prices within individual categories remained steady.”